BDBM50023751 19-Benzyl-13-carbamoylmethyl-22-(4-ethoxy-benzyl)-16-isopropyl-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentaaza-spiro[5.19]pentacosane-10-carboxylic acid [(1-carbamoyl-4-guanidino-butylcarbamoyl)-methyl]-(3-guanidino-propyl)-amide::CHEMBL2372281
SMILES CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSCC(C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1
InChI Key InChIKey=LFHUCYXSNZFEMG-UHFFFAOYSA-N
Data 2 KI
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 50023751
Affinity DataKi: 1.50E+6nMAssay Description:In vitro antagonist activity was measured by inhibition of vasopressin-stimulated adenylate cyclase in renal medullary preparation in dogMore data for this Ligand-Target Pair
Affinity DataKi: 1.50E+6nMAssay Description:In vitro antagonist activity was measured by inhibition of vasopressin-stimulated adenylate cyclase in renal medullary preparation in humanMore data for this Ligand-Target Pair
